Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Operations (QoQ)Cash from Operations Growth (1y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)Enterprise Value (QoQ)Enterprise Value Growth (1y)FCF Margin (QoQ)FCF Margin Growth (1y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Revenue (QoQ)Revenue Growth (1y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Total Debt (QoQ)
Income Statement
Cardiol Therapeutics (CRDL) Free Cash Flow (QoQ): 2021-2022
Generated on {Timestamp}
© BusinessQuant.com
Generated on {Timestamp}
Powered by
Peer Comparison
Historic Data
Download Data 🔒| Date | Value |
|---|---|